Abbott Laboratories
Latest Abbott Laboratories News and Updates
Company & Industry OverviewsHow Is Boston Scientific’s Geographic Strategy Driving Growth?
Boston Scientific has strategically expanded in these geographies through organic as well as inorganic strategies. Company & Industry OverviewsA Brief Look at Boston Scientific’s Business Model
Boston Scientific’s (BSX) Cardiovascular segment consists of minimally invasive technologies to treat patients with a wide range of heart and vascular diseases. It is BSX’s largest business segment and generated ~39% of the company’s total revenues in 2015. Company & Industry OverviewsOverview of Boston Scientific, a Leading Medical Device Company
Starting in 2011, Boston Scientific (BSX) has undertaken cost-cutting programs and reorganization efforts to turn the company’s battered financials around. In 2014, BSX started registering positive growth and profitability. MiscellaneousRationale for the St. Jude Medical-Abbott Merger Transaction
Abbott Labs is buying St. Jude Medical for about $30 billion in cash, stock, and assumed debt to become a dominant player in the cardiovascular health space. MiscellaneousAbbott Buys St. Jude Medical for $85 per Share in Cash and Stock
On April 28, Abbott Labs and St. Jude Medical announced an agreement where Abbott will buy St. Jude for $30 billion in cash, stock, and assumed debt. Company & Industry OverviewsWhy Abbott Laboratories Is a Leader in Nutritional Products
Abbott Laboratories’ Nutritional Products segment is the company’s leading segment, growing at a fast pace, with rapidly increasing margins and revenues. Company & Industry OverviewsWhy Medtronic Is Diversifying beyond Medical Devices
Medtronic established a services and solutions growth vector as one of its core strategies. It contributed ~20 basis points to Medtronic’s growth in 3Q16. Company & Industry OverviewsHow Is Medtronic’s Globalization Strategy Driving Its Growth?
Medtronic’s (MDT) growth is driven by three of the company’s core strategies—therapy innovation, globalization, and economic value. Company & Industry OverviewsBehind Becton Dickinson’s Strategic Restructuring and Business Consolidation
To better position itself amid the changing medical device environment, Becton Dickinson has come to focus on restructuring and business model evolution. Company & Industry OverviewsHow Do Johnson & Johnson’s Valuations Compare to Peers?
On March 17, 2016, Johnson & Johnson (JNJ) was trading at a forward PE (price-to-earnings) multiple of ~16.5x compared to the industry average of ~19.6x. Company & Industry OverviewsHow Baxter’s Biosciences Spin-off into Baxalta Improved Its Valuation
On July 1, 2015, Baxter separated its Biosciences division into a new entity named Baxalta in an effort to divest risky segments and streamline operations. Company & Industry OverviewsThe Geographic Strategy of Thermo Fisher Scientific
Thermo Fisher Scientific is a global company, but the majority of its revenues are generated from the developed markets. The US is its largest market, generating ~48% of the company’s total revenues. Company & Industry OverviewsDissecting Abbott Laboratories: A Key Business Model Analysis
Since 2013, Abbott Laboratories has generated revenues from a diversified healthcare business spanning across geographies and four primary segments. Company & Industry OverviewsSpecialty Diagnostics Segment of Thermo Fisher Scientific
A leading provider of diagnostic products and services, Thermo Fisher Scientific (TMO) has witnessed strong recurring revenues and high margins in the Specialty Diagnostics Segment over the years. Company & Industry OverviewsThe Life Sciences Solutions Segment of Thermo Fisher Scientific
Thermo Fisher Scientific’s Life Sciences Solutions segment earned revenues of ~$4.2 billion in 2014, representing organic growth of around 4%. Company & Industry OverviewsThermo Fisher Scientific’s Laboratory Products and Services Segment
Thermo Fisher Scientific’s Laboratory Products and Services segment earned revenues of approximately $6.6 billion in 2014, representing organic growth of around 5%. Company & Industry OverviewsThermo Fisher Scientific: A Leading Medical Technology Company
Thermo Fisher Scientific (TMO) is one of the leading medical technology companies in the world, providing a broad portfolio of laboratory equipment and services. Company & Industry OverviewsA Key Look at Abbott Laboratories’ Acquisitions and Divestments
Inorganic growth through acquisitions has led to the expansion of Abbott Laboratories across geographies and to the broadening of its product portfolio. Company & Industry OverviewsEstablished Pharmaceuticals Segment of Abbott Laboratories
Abbott’s Established Pharmaceuticals segment is a consumer-oriented segment with a consumer mix of around 75% self-pay consumers and 25% third-party payers. Company & Industry OverviewsMapping Abbott Laboratories’ Geographic Strategy
Abbott Laboratories is a global healthcare company that sees 70% of its total revenues generated in markets outside the United States. Company & Industry OverviewsA Rundown of Abbott Laboratories’ Diagnostic Products Segment
Abbott Laboratories is one of the leading companies in the diagnostic products space in the United States, with sales of around $4.7 billion in 2014. Company & Industry OverviewsIntroducing Abbott Laboratories, a Leading Global Healthcare Company
Abbott Laboratories operates across more than 150 countries, employs over 73,000 people, and is the global leader in the nutrition subsector. Company & Industry OverviewsAnalyzing Becton, Dickinson and Company’s Geographic Strategy
Becton, Dickinson and Company (BDX), or BD, has operations across the globe, with more than 50% of its 2015 revenues coming from international markets. Company & Industry OverviewsBecton, Dickinson and Company: A Leading Global Medical Device Company
Becton, Dickinson and Company, or BD, headquartered in Franklin Lakes, New Jersey, is one of the leading medical technology companies in the United States. Company & Industry OverviewsWhy Technology Is a Key Driver in the US Medical Device Industry
Traditionally, the United States has been home to the most advanced technological inventions in the medical device industry. Company & Industry OverviewsAnalyzing the Competitive Landscape of the Medical Device Industry
The medical device industry in the US consists of a few big players and a large number of small and medium enterprises. Company & Industry OverviewsHow Does the FDA Classify Medical Devices?
Medical devices are classified as per the level of control required by the Food, Drug, and Cosmetic Act (or FD&C Act). Company & Industry OverviewsHow Do Commodity Prices Impact the Medical Device Industry?
Medical device manufacturers source various medical components and parts from suppliers in order to assemble or develop medical devices. Company & Industry OverviewsProbing Medtronic’s Research and Development Pipeline
Medtronic spent ~$1.6 billion—approximately 8.1% of its total sales—on research and development programs in fiscal 2015. Company & Industry OverviewsGauging Medtronic’s Geographic Strategy in 2015
Medtronic’s US market YoY growth rate was 22% in 2015, compared to a 2% growth in 2014, whereas its emerging markets have grown by 23% in 2015. Company & Industry OverviewsEvaluating Medtronic’s Cardiac and Vascular Devices Segment
Medtronic’s Cardiac and Vascular segment consists of Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular. Company & Industry OverviewsHow Is the Medical Device Industry Segmented?
The US medical devices industry can be categorized according to the field of medicine in which a device is used. Company & Industry OverviewsAbbVie: An Investor’s Look at a Leading Biotechnology Company
With a market capitalization of $100.7 billion, AbbVie is a major US biopharmaceutical company. AbbVie competes with Amgen, Gilead Sciences, and Bristol-Myers Squibb . Company & Industry OverviewsWhy Abbott’s Business Is Susceptible to Numerous Risks
Abbott deals with innovative devices and established pharmaceutical products. Any infringement of intellectual property rights may lead to huge losses. Company & Industry OverviewsAbbott Laboratories’ Associated Business Segments
Abbott is organized around a broad portfolio—established pharmaceutical products, diagnostic products, nutritional products, and vascular products. ConsumerChilton Investment Company sells its shares in CarMax in 4Q13
Chilton liquidated its position in CarMax Inc. (KMX) in the fourth quarter that had accounted for 0.71% of the fund’s third quarter portfolio.